ASTRO/AUA/SUO Clinically Localized Prostate Cancer Guideline Summary - Guideline Central

Design and created by Guideline Central in participation with the American Society for Radiation Oncology, American Urological Association, and Society of Urologic Oncology.

Document Overview

Document Title: Clinically Localized Prostate Cancer

Authoring Societies

American Society for Radiation Oncology

American Urological Association

Society of Urologic Oncology

Document Publication Date: Mar 1, 2018

Page Last Reviewed/Updated: Apr 7, 2026

Document Type: Guideline

Country of Publication: United States

Full Text Freely Available: Yes

Full Text Guideline: www.auajournals.org/doi/10.1016/j.juro.2017.11.095

Source Citation: Sanda, M. G., Cadeddu, J. A., Kirkby, E., Chen, R. C., Crispino, T., Fontanarosa, J., … Treadwell, J. R. (2018). Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options. The Journal of Urology, 199(3), 683–690. doi:10.1016/j.juro.2017.11.095

Supplemental Implementation Resources

Document Scope, Criteria, and Use Cases

Scope: Assessment and Screening, Management, Treatment

Diseases/Conditions (MeSH): D011471 - Prostatic Neoplasms

Keywords: prostate cancer, prostatic neoplasms

Inclusion Criteria: Male, Adult, Older Adult

Health Care Settings: Hospital, Operating and Recovery Room, Outpatient

Intended Users: Nurse, Nurse Practitioner, Physician, Physician Assistant

Recommendation Development Processes & Methodology

Number of Source Documents: 342

Literature Search Start Date: Monday, January 1, 2007

Literature Search End Date: Monday, August 1, 2016

Includes peer/external review process?: Yes

Includes public comment process?: No

Methodologist involvement?: Yes

Patient involvement?: No

Includes multi-disciplinary group?: Yes

Includes systematic review?: Yes

Grades quality of strength of evidence?: Yes

Grades quality of strength of recommendation?: Yes

Discloses funding source?: Yes

Discloses conflicts of interest?: Yes

Includes benefits/harms analysis with recommendations?: Yes